First Time Loading...

Sierra Oncology Inc
NASDAQ:SRRA

Watchlist Manager
Sierra Oncology Inc Logo
Sierra Oncology Inc
NASDAQ:SRRA
Watchlist
Price: 54.99 USD Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

280m
+156%
Assets
Growth Rates:
1 Year
+153%
3 Years
+191%
5 Years
+122%
7 Years
+671%
10 Years
-
18.4m
+37%
Liabilities
Growth Rates:
1 Year
+104%
3 Years
+47%
5 Years
+253%
7 Years
+142%
10 Years
-
261.6m
+173%
Equity
Growth Rates:
1 Year
+158%
3 Years
+213%
5 Years
+116%
7 Years
+812%
10 Years
-

Balance Sheet Decomposition
Sierra Oncology Inc

280m
Assets
18.4m
Liabilities
280m
Assets
18.4m
Liabilities
Current Assets 278.2m
Cash & Short-Term Investments 274m
Receivables 270k
Other Current Assets 3.9m
Non-Current Assets 1.8m
PP&E 840k
Other Non-Current Assets 960k
Current Liabilities 13.1m
Accounts Payable 1.8m
Accrued Liabilities 11.3m
Non-Current Liabilities 5.3m
Long-Term Debt 4.9m
Other Non-Current Liabilities 440k

Balance Sheet
Sierra Oncology Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
2
29
150
109
100
106
148
104
105
Cash
0
1
2
2
0
1
1
2
2
Cash Equivalents
2
28
149
107
100
105
146
102
103
Short-Term Investments
0
10
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
1
0
0
0
Other Current Assets
0
1
2
1
1
2
2
2
2
Total Current Assets
3
40
152
110
102
109
150
107
107
PP&E Net
0
0
1
0
0
0
1
0
1
PP&E Gross
0
0
1
0
0
0
1
0
1
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
1
0
0
0
1
1
1
1
Total Assets
3
N/A
41
+1 524%
153
+276%
111
-27%
102
-8%
110
+7%
151
+38%
108
-29%
109
+2%
Liabilities
Accounts Payable
0
1
0
3
1
1
1
2
2
Accrued Liabilities
1
2
7
5
6
9
7
7
11
Short-Term Debt
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
56
0
0
Total Current Liabilities
1
2
7
8
8
10
65
9
13
Long-Term Debt
0
0
0
0
0
5
0
0
0
Other Liabilities
1
2
0
0
0
0
0
0
0
Total Liabilities
2
N/A
4
+122%
7
+85%
8
+4%
8
-3%
15
+100%
65
+333%
10
-85%
13
+41%
Equity
Common Stock
37
144
0
0
0
0
0
0
0
Retained Earnings
35
108
534
582
624
677
766
847
941
Additional Paid In Capital
0
0
680
685
719
772
852
945
1 037
Other Equity
1
0
0
0
0
0
0
0
0
Total Equity
1
N/A
37
+5 129%
145
+297%
103
-29%
95
-8%
95
0%
86
-9%
98
+14%
96
-2%
Total Liabilities & Equity
3
N/A
41
+1 524%
153
+276%
111
-27%
102
-8%
110
+7%
151
+38%
108
-29%
109
+2%
Shares Outstanding
Common Shares Outstanding
4
4
1
1
1
2
2
11
16
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0

See Also

Summary
SRRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRRA stock valuation using valuation multiples.
Wall Street Estimates
SRRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.